124 related articles for article (PubMed ID: 9808439)
1. Stereology of the myocardium in hypertensive rats. Differences in relation to the time of inhibition of nitric oxide synthesis.
Pereira LM; Vianna GM; Mandarim-de-Lacerda CA
Virchows Arch; 1998 Oct; 433(4):369-73. PubMed ID: 9808439
[TBL] [Abstract][Full Text] [Related]
2. [Morphology and stereology of the myocardium in hypertensive rats. Correlation with the time of nitric oxide synthesis inhibition].
Pereira LM; Vianna GM; Mandarim-de-Lacerda CA
Arq Bras Cardiol; 1998 Jun; 70(6):397-402. PubMed ID: 9713081
[TBL] [Abstract][Full Text] [Related]
3. Stereology and immunohistochemistry of the myocardium in experimental hypertension: long-term and low-dosage administration of inhibitor of the nitric oxide synthesis.
Gomes Pessanha M; Mandarim-de-Lacerda CA; Dumas Hahn M
Pathobiology; 1999; 67(1):26-33. PubMed ID: 9873225
[TBL] [Abstract][Full Text] [Related]
4. [The stereology of the myocardium in rats hypertensive due to the use of an inhibitor of nitric oxide synthesis].
Pereira LM; Mandarim-de-Lacerda CA
Rev Port Cardiol; 1997 Oct; 16(10):753-9, 743. PubMed ID: 9479938
[TBL] [Abstract][Full Text] [Related]
5. Quantitative study of myocardial microcirculation in arterial hypertension due to progressive inhibition of NO synthesis.
Pereira LM; Mandarim-De-Lacerda CA
Arq Bras Cardiol; 1999 Nov; 73(5):407-18. PubMed ID: 10887361
[TBL] [Abstract][Full Text] [Related]
6. Myocardial microcirculation stereological changes in rats subjected to nitric oxide synthesis inhibition.
Pereira LM; Mandarim-De-Lacerda CA
Pathol Res Pract; 1999; 195(3):177-81. PubMed ID: 10220798
[TBL] [Abstract][Full Text] [Related]
7. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of enalapril in spontaneously hypertensive rats cardiac remodeling with nitric oxide synthesis blockade.
de Andrade Zorzi RL; Meirelles Pereira LM; Mandarim-de-Lacerda CA
J Cell Mol Med; 2002; 6(4):599-608. PubMed ID: 12611644
[TBL] [Abstract][Full Text] [Related]
9. Effect of antihypertensive drugs on the myocardial microvessels in rats with nitric oxide blockade.
Meirelles Pereira LM; Mandarim-de-Lacerda CA
Pathol Res Pract; 2000; 196(5):305-11. PubMed ID: 10834387
[TBL] [Abstract][Full Text] [Related]
10. Influence of the chronic nitric oxide synthesis inhibition on cardiomyocytes number.
Pessanha MG; Mandarim-de-Lacerda CA
Virchows Arch; 2000 Dec; 437(6):667-74. PubMed ID: 11193480
[TBL] [Abstract][Full Text] [Related]
11. Quantitative examination of the cardiac myocytes in hypertensive rats under chronic inhibition of nitric oxide synthesis.
Pereira LM; Mandarim-de-Lacerda CA
J Biomed Sci; 1998; 5(5):363-9. PubMed ID: 9758910
[No Abstract] [Full Text] [Related]
12. Oxytalan elastic and collagen fibers during the repair process in experimental nitric oxide inhibition.
Xavier-Vidal R
Clinics (Sao Paulo); 2005 Apr; 60(2):85-92. PubMed ID: 15880243
[TBL] [Abstract][Full Text] [Related]
13. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
Ye VZ; Hodge G; Yong JL; Duggan KA
Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
[TBL] [Abstract][Full Text] [Related]
15. Non-specific inhibitors of nitric oxide synthase cause myocardial necrosis in the rat.
Moreno Júnior H; Nathan LP; Metze K; Costa SK; Antunes E; Hyslop S; Zatz R; de Nucci G
Clin Exp Pharmacol Physiol; 1997 May; 24(5):349-52. PubMed ID: 9143786
[TBL] [Abstract][Full Text] [Related]
16. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
[TBL] [Abstract][Full Text] [Related]
17. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR.
Ono Y; Ono H; Matsuoka H; Fujimori T; Frohlich ED
Hypertension; 1999 Oct; 34(4 Pt 1):609-16. PubMed ID: 10523335
[TBL] [Abstract][Full Text] [Related]
19. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H
Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445
[TBL] [Abstract][Full Text] [Related]
20. Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition.
Mandarim-De-Lacerda CA; Meirelles Pereira LM
Pathobiology; 2000; 68(1):36-42. PubMed ID: 10859529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
